Failure of pre-exposure prophylaxis with daily tenofovir/emtricitabine and the scenario of delayed HIV seroconversion
International Journal of Infectious Diseases
; 94:41-43, 2020.
Article
in English
| CAB Abstracts | ID: covidwho-1409649
ABSTRACT
Failure of pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate and emtricitabine may occur despite perfect adherence, although this is uncommon. Failure results in breakthrough HIV infection. Delayed seroconversion associated with antiretroviral use may complicate the picture, causing uncertainties in interpreting adherence patterns for establishing the true cause of PrEP failure.
Full text:
Available
Collection:
Databases of international organizations
Database:
CAB Abstracts
Language:
English
Journal:
International Journal of Infectious Diseases
Year:
2020
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS